Moreover, we found that higher expressions of METTL3, METTL14, and hnRNPA2B1 in the NB cohort (n = 498) were significantly associated with poor event-free survival (EFS) (Figure 6L; Supplementary Figure S6H). The gene discussed is METTL14; the disease is neuroblastoma.